
    
      A total of 20 patients with bilateral symmetrical vernal keratoconjunctivitis will be
      included. Each patient will undergo a complete ophthalmologic evaluation. Patient will be
      placed at random on topical Tacrolimus 0.01% ophthalmic solution in one eye and placebo
      eyedrops in the fellow eye. Patients will undergo ophthalmologic examination at one week and
      after one month. Photos will be taken. The outcome measures include graded symptoms, graded
      signs, and laboratory investigations. Symptoms of itching, redness, foreign body sensation,
      tearing and discharge following will be recorded before and after treatment. The grading of
      clinical signs of conjunctival hyperemia, conjunctival papillary hypertrophy, perilimbal
      infiltrates, Trantas dots, superficial punctate keratopathy will be recorded before and after
      treatment. Conjunctival surface temperature will be determined before and after treatment.
      Conjunctival scrapings will be stained with Giemsa and will be assessed before and after
      therapy and number of eosinophils per hpf will be determined and recorded.
    
  